Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Neste Corporation - Managers' Transactions, Ala-Härkönen (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 14 March 2024 at 6:30 p.m. (EET)Person subject to the notification requirementName: Ala-Härkönen, MarttiPosition: Chief Financial OfficerIssuer: Neste CorporationLEI: 5493009GY1X8GQ66AM14 Notification type: INITIAL NOTIFICATIONReference number: 5493009GY1X8GQ66AM14_20240314144512_56____________________________________________ Transaction date: 2024-03-14Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2577 Unit

Neste Corporation - Managers' Transactions, Leenders (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 14 March 2024 at 6:30 p.m. (EET)Person subject to the notification requirementName: Leenders, BartPosition: Other senior managerIssuer: Neste CorporationLEI: 5493009GY1X8GQ66AM14 Notification type: INITIAL NOTIFICATIONReference number: 5493009GY1X8GQ66AM14_20240314144447_54____________________________________________ Transaction date: 2024-03-14Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 88 Unit price: 0.00

Neste Corporation - Managers' Transactions, Ståhlberg (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 14 March 2024 at 6:30 p.m. (EET)Person subject to the notification requirementName: Ståhlberg, ChristianPosition: Other senior managerIssuer: Neste CorporationLEI: 5493009GY1X8GQ66AM14 Notification type: INITIAL NOTIFICATIONReference number: 5493009GY1X8GQ66AM14_20240314144447_52____________________________________________ Transaction date: 2024-03-14Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 150 Unit price:

Neste Corporation - Managers' Transactions, Kopra (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 14 March 2024 at 6:30 p.m. (EET)Person subject to the notification requirementName: Kopra, PanuPosition: Other senior managerIssuer: Neste CorporationLEI: 5493009GY1X8GQ66AM14 Notification type: INITIAL NOTIFICATIONReference number: 5493009GY1X8GQ66AM14_20240314144447_51____________________________________________ Transaction date: 2024-03-14Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 162 Unit price: 0.00

Don de Bethizy has been engaged as Senior Advisor to the Executive Management and Board of Directors of Cereno Scientific

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that Don de Bethizy has been engaged as Senior Advisor to the Executive Management and Board of Directors of Cereno Scientific, to support the company in reaching its strategic growth objectives.J. Donald (Don) de Bethizy, PhD has more than 30 years of experience in managing and financing life science-related technologies and has played a key role in building and advising several life sciences companies. Don de Bethizy advised the CEO and

Carthesian Therapeutics terminates Genovis Licence Agreement

On 21 October 2021 Genovis entered into a license agreement with Selecta Biocience/Carhtesian Therapeutics. This license agreement has now been terminated by Carthesian Therapeutics and all right to the unique Xork™ enzyme are returned to Genovis. This opens up for new business opportunities with other partners within gene therapy and autoimmune diseases.Substantial resources have already been invested in the project, which now will be for the benefit of Genovis, amongst other items second and third generation of the Xork enzyme with corresponding patent applications. Currently there are no

#24-93 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Cereno Scientific's nomination committee proposes Dr. Gunnar Olsson and CEO Sten R. Sörensen as new members of the Board of Directors

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the nomination committee’s proposed resolutions for the 2024 annual general meeting includes the new election of Dr. Gunnar Olsson and Cereno’s CEO Sten R. Sörensen as new members of the Board of Directors. The nomination committee proposes re-election of board members Anders Svensson and Jeppe Øvlesen as well as new election of board members Dr. Gunnar Olsson and CEO Sten R. Sörensen.”Cereno is currently taking great strides in both

YIT has, for fulfilment of the terms of the convertible notes announced on 12 March 2024, resolved on a directed share issue of up to 16 million shares

YIT Corporation Stock Exchange Release 14 March 2024 at 18:10 p.m.YIT has, for fulfilment of the terms of the convertible notes announced on 12 March 2024, resolved on a directed share issue of up to 16 million shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, SOUTH AFRICA, SINGAPORE, NEW ZEALAND OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.YIT Corporation announced on 12 March 2024 a

The Nomination Committee’s proposed resolution to the Annual General Meeting on 16 April 2024

The Nomination Committee in Cereno Scientific AB (publ) (the “Company”) proposes the following resolutions to the Annual General Meeting on 16 April 2024, which relate to items 2 and 10-13 on the proposed agenda in the notice to the Annual General Meeting. In accordance with the principles adopted by the previous Annual General Meeting, the Nominating Committee has consisted of Cihan Punar, Sverker Jern, and Joakim Söderström.Election of chairperson of the meeting The Nomination Committee proposes Fredrik Brusberg, associate at MAQS Advokatbyrå, or, in the event of an impediment, the

Embrace the power of technology in Stellaris new expansion The Machine Age

Discover new possibilities and features for machine empires, a new Endgame Crisis, a new Crisis Path and much more in this major expansionSTOCKHOLM, MARCH 14 - Today, Paradox Interactive announced The Machine Age, a new expansion for its sci-fi strategy game Stellaris. Scientists have discovered advanced means to commune with the machine, enabling life to overcome the biological limitations of minds and flesh. The Machine Age begins a time of technical glory, but raises new ethical and social dilemmas. With those times of unleashed ambition, new threats will emerge, questioning the real

Cereno Scientific brings forward the publication of the Annual Report

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, has resolved to bring forward the publication of the Annual Report for the financial year 2023 to 26 March 2024Previously communicated was that the publication of the Annual Report for the financial year 2023 would take place during week 16, 2024, but the publication is now brought forward to 26 March 2024. The reason for the bringing forward the publication is that the Board of Directors has resolved to bring forward the Annual General Meeting to 16 April

Home Dialysis Risk Prevention Act addressed in House Committee on Ways and Means Hearing

On March 12, 2024, the House Committee on Ways and Means Chairman Jason Smith (MO-08) held a Hearing to examine opportunities and challenges in enhancing access to care in patients´ home and modernizing care in rural and underserved communities. The Hearing was titled, “Enhancing Access to Care at Home in Rural and Underserved Communities.” and during the Hearing Rep. Adrian Smith (NE-03) made the following remarks: “Thank you to all our witnesses for joining us today to talk about this important topic. It is amazing to see how new technologies have expanded the boundaries of access

White Pearl Technology Group postpones Annual Report 2023 and AGM

White Pearl Technology Group AB (WPTG) announces adjustments to its Financial Calendar, postponing the publication of the Annual Report for 2023 and the Annual General Meeting (AGM) for 2024. The Annual Report for 2023 will now be published on April 22nd, 2024, rather than the previously scheduled date of March 26th, 2024. Similarly, the AGM is rescheduled to take place on May 13th, 2024, instead of the initially communicated date of April 26th, 2024. Updated Financial Calendar 2024: Dates in 2024 22nd of April: Annual Report 2023 13th of May: Annual General Meeting 31st

#24-24 Split of shares in SBF Bostad AB

At the extraordinary general meeting of SBF Bostad AB (“the Company”) on March 7, 2024, it was decided to split the Company’s shares whereby one (1) existing share, regardless of share class, is split into ten (10) new shares (10:1) of the same share class. The board of the Company has now, with the support of the authorization from the extraordinary general meeting, decided that the record date for the split shall be March 19, 2024. The last day of trading before the split is March 15, 2024. The first day of trading after the split is March 18, 2024. Please note that the shares will be

New discovery reveals how the egg controls sperm entry

After the egg has been fertilized by a sperm, the surrounding egg coat tightens, mechanically preventing the entry of additional sperm and the ensuing death of the embryo. This is according to a new study led by researchers at Karolinska Institutet and published in the journal Cell. The work also explains how mutations in egg coat proteins can cause female infertility and may eventually lead to new contraceptive methods.Fertilization in mammals begins when a sperm attaches to the egg coat, a filamentous extracellular envelope that sperm must penetrate in order to fuse with the egg. Now an

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OFCERENO Scientific AB (PUBL)

The shareholders of Cereno Scientific AB (publ), company registration no. 556890-4071 (the “Company”), are hereby given notice to attend the Annual General Meeting to be held on Tuesday 16 April 2024 at 11 a.m. at MAQS Advokatbyrå’s premises, at the address Östra Hamngatan 24 in Gothenburg. Registration for the Annual General Meeting will commence at 10.30 a.m. Registration of attendance at the Annual General Meeting will be cancelled when the general meeting opens. Right to participate at the Annual General Meeting Any shareholder wishing to participate at the Annual General Meeting

Joint groundbreaking for Logistics Position Ramlösa in Helsingborg

On Thursday, March 14, a symbolic groundbreaking was held for the new Logistics Position Ramlösa in Helsingborg.14 March 2024, 15.30 p.m. CEST The groundbreaking for the 75,000 sqm logistic property was jointly performed by Jörgen Eriksson, CEO of Catena, Johan Kallin, CEO of Nowaste Logistics, Jan Björklund (S), Vice Chairman of the City Council of Helsingborg, and Alexander Svensson (M), Chairman of the City Planning Committee of Helsingborg City. An Aroma apple tree, the provincial apple of Skåne, was planted at the site in connection with the groundbreaking, intended to grow at the

Kongsberg Automotive has completed its share buyback program.

As previously announced, Kongsberg Automotive ASA (KA) has executed a buyback program of up to 2.5% of its outstanding shares in the market since November 17, 2023. Danske Bank has acted as an advisor for KA. Date Aggregated Daily Weighted Total Volume (# of Average Price Transaction Shares) (NOK) Value(NOK)March 05, 2024 300,000 1.63 490,620March 06, 2024 300,000 1.64 491,460March 07, 2024 300,000 1.64 491,580March 08,

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B62Z3C74 Issuer Name Fidelity China Special Situations PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights; An event changing the breakdown of voting rights 3. Details of person subject to the notification obligation Name FIL Limited City of registered office (if applicable) Hamilton Country of registered office (if applicable) Bermuda 4. Details of the shareholder Full name of shareholder(s) if different from

ABS Wavesight™ Nautical Systems Now Supports Fully Digital, Streamlined SIRE 2.0 Inspections

HSQE and Vetting Manager Module Enhancements Put ABS Wavesight™ Nautical Systems at the Forefront of the Transition to SIRE 2.0 (HOUSTON) — Enhancements to the HSQE and Vetting Manager module enable owners to transition to SIRE 2.0’s risk-based approach, which allows better management of areas of vulnerability, while also helping operators assess future vessel performance. The enhanced module now collects pre-inspection data, including areas of concern and risk assessment metrics that is compiled and digitized in one place and is easily transferable to inspectors transitioning

There are no items matching the current filter
There are no more items matching the current filter
Back to top